Press release

September 2015

FDA Accepts SCILEX Pharmaceuticals’ NDA Filing for ZTlido™

September 17, 2015

Malvern, PA, September 16, 2015 – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that the FDA has accepted for filing its new drug application for ZTlido™ (lidocaine patch 1.8%). This marks a significant step on the path to commercialization for ZTlido™, … Continue reading FDA Accepts SCILEX Pharmaceuticals’ NDA Filing for ZTlido™
X

Share This Page

XS SM MD LG XL